A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
Clinical trial NCT02540330 · TERMINATED
Trial details
- NCT number
- NCT02540330
- Sponsor
- Atossa Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2020-08-13
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.